🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-02-07
Trial ID
NCT02111850
This is a Phase 1 dose-finding study of FT-516 in combination with monoclon...
Status
Terminated
Location
University of Minnesota Masonic Cancer Center
Start Date
2020-09-07
Trial ID
NCT04551885
Treatments Being Tested
This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-11-10
Trial ID
NCT05182073
This study is being conducted in patients with newly diagnosed breast cance...
Status
Completed
Location
Columbia University Irving Medical Center
Start Date
2012-10
Trial ID
NCT01847001
The primary objective of this trial is to investigate whether the addition ...
Status
Recruiting
Location
Institut Bergonie
Start Date
2019-02-14
Trial ID
NCT03805022
ATHENA chimeric antigen receptor (CAR)-T, a CD19-directed CAR-T cell immuno...
Status
Recruiting
Location
Biotherapeutic Department, Chinese PLA General Hospital
Start Date
2023-09-06
Trial ID
NCT06014073
This study investigates the activity of a new regimen of treatment for pati...
Status
Completed
Location
Gastrointestinal Oncology Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center, Belinson Campus,
Start Date
2015-01
Trial ID
NCT02280694
Treatments Being Tested
This is an open, single-arm, clinical study to evaluate the efficacy and sa...
Status
Recruiting
Location
District One Hospital
Start Date
2024-05-29
Trial ID
NCT06428188
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07
Trial ID
NCT07153289
Treatments Being Tested
This is a prospective, multicentric, randomized, open label Phase II trial ...
Status
Terminated
Location
Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet
Start Date
2017-07-07
Trial ID
NCT02808247
Treatments Being Tested